image
Healthcare - Medical - Healthcare Information Services - NASDAQ - US
$ 2.0
-1.48 %
$ 62.2 M
Market Cap
66.67
P/E
1. INTRINSIC VALUE

Forian Inc. provides software solutions, proprietary data driven insights, and predictive analytics to optimize the operational, clinical, and financial performance of its healthcare, cannabis, and government customers. It operates through three segments: Information & Software, Services, and Other. The company's products include BioTrack, a vertically integrated point of sale, manufacturing, delivery, and cultivator software solution for dispensaries, cultivators, manufacturers, and distributors; and Cannalytics, a Software as a Service based analytics solution that provides clients with a presentation of business performance. Its products also comprise BioTrack seed-to-sale compliance traceability platform, which is used to manage the tracking and tracing of various cannabis products from cultivation to sale; BioTrack State Traceability & Enforcement Monitoring System to ensure transparency and accountability throughout cannabis supply chain; and STEMS, a seed-to-sale tracking module, to provide cannabis program management solution to cannabis regulatory agencies.[ Read More ]

The intrinsic value of one FORA stock under the base case scenario is HIDDEN Compared to the current market price of 2 USD, Forian Inc. is HIDDEN

2. FUNDAMENTAL ANALYSIS

Price Chart FORA

image
FINANCIALS
20.5 M REVENUE
-26.87%
-5.6 M OPERATING INCOME
72.72%
1.73 M NET INCOME
106.67%
729 K OPERATING CASH FLOW
108.31%
7.12 M INVESTING CASH FLOW
210.20%
-4.6 M FINANCING CASH FLOW
-4477.35%
4.69 M REVENUE
-1.90%
-796 K OPERATING INCOME
73.21%
-205 K NET INCOME
91.97%
764 K OPERATING CASH FLOW
3406.34%
31.8 K INVESTING CASH FLOW
-96.85%
-87.4 K FINANCING CASH FLOW
-352.74%
Balance Sheet Decomposition Forian Inc.
image
Current Assets 57.3 M
Cash & Short-Term Investments 48.3 M
Receivables 3.7 M
Other Current Assets 5.24 M
Non-Current Assets 1.61 M
Long-Term Investments 0
PP&E 86.7 K
Other Non-Current Assets 1.52 M
Current Liabilities 6.84 M
Accounts Payable 162 K
Short-Term Debt 21.3 K
Other Current Liabilities 6.66 M
Non-Current Liabilities 25.9 M
Long-Term Debt 24.9 M
Other Non-Current Liabilities 1 M
EFFICIENCY
Earnings Waterfall Forian Inc.
image
Revenue 20.5 M
Cost Of Revenue 5.48 M
Gross Profit 15 M
Operating Expenses 20.6 M
Operating Income -5.6 M
Other Expenses -7.33 M
Net Income 1.73 M
RATIOS
73.26% GROSS MARGIN
73.26%
-27.32% OPERATING MARGIN
-27.32%
54.23% NET MARGIN
54.23%
42.42% ROE
42.42%
18.86% ROA
18.86%
-10.44% ROIC
-10.44%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis Forian Inc.
image
Net Income 1.73 M
Depreciation & Amortization 96.3 K
Capital Expenditures -75.5 K
Stock-Based Compensation 6.57 M
Change in Working Capital -264 K
Others -7.88 M
Free Cash Flow 653 K
3. WALL STREET ANALYSTS ESTIMATES
Wall Street Analysts Price Targets Forian Inc.
image
Wall Street analysts predict an average 1-year price target for FORA of $4.5 , with forecasts ranging from a low of $4.5 to a high of $4.5 .
FORA Lowest Price Target Wall Street Target
4.5 USD 125.00%
FORA Average Price Target Wall Street Target
4.5 USD 125.00%
FORA Highest Price Target Wall Street Target
4.5 USD 125.00%
4. DIVIDEND ANALYSIS
0.00% DIVIDEND YIELD
0 USD DIVIDEND PER SHARE
5. COMPETITION
6. Ownership
Insider Ownership Forian Inc.
image
Sold
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
0 USD 0
Bought
0 USD 0
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
Date Value Insider Amount Avg Price
1 year ago
Oct 04, 2023
Bought 4.05 K USD
WYGOD MARTIN J
Director
+ 1700
2.38 USD
1 year ago
May 31, 2023
Bought 11.5 K USD
WYGOD MARTIN J
Director
+ 4789
2.4 USD
1 year ago
May 30, 2023
Bought 10.9 K USD
WYGOD MARTIN J
Director
+ 4565
2.39 USD
1 year ago
May 25, 2023
Bought 7.02 K USD
WYGOD MARTIN J
Director
+ 3000
2.34 USD
1 year ago
May 24, 2023
Bought 3.12 K USD
WYGOD MARTIN J
Director
+ 1327
2.35 USD
1 year ago
May 23, 2023
Bought 14.3 K USD
WYGOD MARTIN J
Director
+ 5999
2.38 USD
1 year ago
May 18, 2023
Bought 12.5 K USD
WYGOD MARTIN J
Director
+ 5444
2.29 USD
1 year ago
May 17, 2023
Bought 29.6 K USD
TROTMAN STANLEY S JR
Director
+ 12343
2.4 USD
1 year ago
May 16, 2023
Bought 18.4 K USD
TROTMAN STANLEY S JR
Director
+ 7657
2.4 USD
1 year ago
Feb 14, 2023
Bought 19.3 K USD
Wygod Max C
+ 5000
3.86 USD
1 year ago
Feb 14, 2023
Bought 41 K USD
WYGOD MARTIN J
+ 10485
3.91 USD
2 years ago
Apr 14, 2022
Bought 14.4 K USD
WYGOD MARTIN J
director:
+ 3150
4.58 USD
2 years ago
Apr 11, 2022
Bought 9.48 K USD
WYGOD MARTIN J
director:
+ 2030
4.67 USD
2 years ago
Apr 06, 2022
Bought 1.09 K USD
WYGOD MARTIN J
director:
+ 202
5.41 USD
2 years ago
Mar 31, 2022
Bought 5.31 K USD
WYGOD MARTIN J
director:
+ 800
6.64 USD
2 years ago
Mar 29, 2022
Bought 64.5 K USD
TROTMAN STANLEY S JR
director:
+ 10000
6.45 USD
2 years ago
Mar 28, 2022
Bought 72.9 K USD
WYGOD MARTIN J
director:
+ 11373
6.41 USD
2 years ago
Feb 14, 2022
Bought 36.8 K USD
WYGOD MARTIN J
+ 4800
7.66 USD
2 years ago
Feb 10, 2022
Bought 38 K USD
WYGOD MARTIN J
+ 4800
7.92 USD
2 years ago
Jan 21, 2022
Bought 12.8 K USD
WYGOD MARTIN J
+ 1600
8.01 USD
2 years ago
Jan 10, 2022
Bought 25 K USD
WYGOD MARTIN J
+ 3200
7.81 USD
2 years ago
Jan 07, 2022
Bought 19.8 K USD
TROTMAN STANLEY S JR
+ 2500
7.91 USD
2 years ago
Jan 05, 2022
Bought 40.2 K USD
TROTMAN STANLEY S JR
+ 5000
8.04 USD
2 years ago
Jan 07, 2022
Bought 51.4 K USD
WYGOD MARTIN J
+ 6518
7.88 USD
2 years ago
Jan 06, 2022
Bought 86.2 USD
WYGOD MARTIN J
+ 11
7.84 USD
2 years ago
Jan 05, 2022
Bought 63.6 K USD
WYGOD MARTIN J
+ 8044
7.91 USD
2 years ago
Dec 22, 2021
Bought 64.4 K USD
TROTMAN STANLEY S JR
+ 7524
8.56 USD
2 years ago
Dec 17, 2021
Bought 20.4 K USD
TROTMAN STANLEY S JR
+ 2473
8.25 USD
2 years ago
Dec 21, 2021
Bought 44.6 K USD
TROTMAN STANLEY S JR
+ 5159
8.64 USD
2 years ago
Dec 20, 2021
Bought 86.8 K USD
TROTMAN STANLEY S JR
+ 10000
8.68 USD
2 years ago
Dec 15, 2021
Bought 12.9 K USD
WYGOD MARTIN J
+ 1654
7.81 USD
2 years ago
Dec 14, 2021
Bought 6.26 K USD
WYGOD MARTIN J
+ 800
7.82 USD
2 years ago
Dec 13, 2021
Bought 53 K USD
WYGOD MARTIN J
+ 6678
7.94 USD
2 years ago
Dec 10, 2021
Bought 241 USD
WYGOD MARTIN J
+ 30
8.04 USD
2 years ago
Dec 06, 2021
Bought 48.8 USD
WYGOD MARTIN J
+ 6
8.14 USD
2 years ago
Dec 03, 2021
Bought 64.8 K USD
WYGOD MARTIN J
+ 8000
8.1 USD
2 years ago
Nov 23, 2021
Bought 58.4 K USD
WYGOD MARTIN J
+ 6400
9.12 USD
2 years ago
Nov 22, 2021
Bought 4.19 K USD
WYGOD MARTIN J
+ 455
9.2 USD
3 years ago
Nov 18, 2021
Bought 98.2 K USD
WYGOD MARTIN J
+ 10071
9.75 USD
3 years ago
Nov 17, 2021
Bought 47.3 K USD
WYGOD MARTIN J
+ 4811
9.83 USD
3 years ago
Oct 14, 2021
Bought 90.4 K USD
WYGOD MARTIN J
+ 9002
10.04 USD
3 years ago
Oct 06, 2021
Bought 30.3 K USD
WYGOD MARTIN J
+ 3000
10.09 USD
3 years ago
Oct 05, 2021
Bought 7.06 K USD
WYGOD MARTIN J
+ 700
10.08 USD
3 years ago
Sep 15, 2021
Bought 78 K USD
WYGOD MARTIN J
+ 7844
9.94 USD
3 years ago
Sep 13, 2021
Bought 40 K USD
WYGOD MARTIN J
+ 4000
10 USD
3 years ago
Jun 08, 2021
Bought 22.2 K USD
Hajj Jennifer
+ 2000
11.11 USD
3 years ago
Jun 07, 2021
Bought 33.5 K USD
Hajj Jennifer
+ 3000
11.155 USD
3 years ago
Jun 01, 2021
Bought 12.9 K USD
WYGOD MARTIN J
+ 1300
9.95 USD
3 years ago
May 25, 2021
Bought 63.9 K USD
WYGOD MARTIN J
+ 6414
9.97 USD
3 years ago
May 21, 2021
Bought 6.04 K USD
WYGOD MARTIN J
+ 610
9.9 USD
3 years ago
May 21, 2021
Bought 79.6 K USD
WYGOD MARTIN J
+ 8000
9.95 USD
3 years ago
May 20, 2021
Bought 170 K USD
WYGOD MARTIN J
+ 17000
10.02 USD
3 years ago
May 19, 2021
Bought 49.7 K USD
WYGOD MARTIN J
+ 5000
9.94 USD
3 years ago
Mar 19, 2021
Bought 33 K USD
TROTMAN STANLEY S JR
+ 2612
12.6278 USD
3 years ago
Mar 18, 2021
Bought 18.1 K USD
TROTMAN STANLEY S JR
+ 1475
12.2671 USD
3 years ago
Mar 17, 2021
Bought 37.6 K USD
TROTMAN STANLEY S JR
+ 3057
12.3086 USD
3 years ago
Mar 16, 2021
Bought 49.7 K USD
TROTMAN STANLEY S JR
+ 4067
12.2125 USD
3 years ago
Mar 15, 2021
Bought 53.8 K USD
TROTMAN STANLEY S JR
+ 4333
12.4161 USD
3 years ago
Mar 12, 2021
Bought 88.7 K USD
TROTMAN STANLEY S JR
+ 7202
12.3152 USD
3 years ago
Mar 11, 2021
Bought 1.21 K USD
TROTMAN STANLEY S JR
+ 100
12.12 USD
3 years ago
Mar 10, 2021
Bought 158 K USD
TROTMAN STANLEY S JR
+ 13241
11.9304 USD
7. News
Forian Inc. (FORA) Q3 2024 Earnings Call Transcript Forian Inc. (NASDAQ:FORA ) Q3 2024 Earnings Conference Call November 13, 2024 4:30 PM ET Company Participants Max Wygod - Executive Chairman and CEO Michael Vesey - CFO Conference Call Participants Richard Baldry - ROTH Capital Operator Greetings, and welcome to Forian Inc. Third Quarter 2024 Financial Results Conference Call and Webcast. At this time, all participants are in a listen only mode. seekingalpha.com - 3 days ago
Forian Inc. (FORA) Surpasses Q3 Earnings Estimates Forian Inc. (FORA) came out with quarterly earnings of $0.03 per share, beating the Zacks Consensus Estimate of $0.01 per share. This compares to earnings of $0.03 per share a year ago. zacks.com - 3 days ago
Forian Inc. Announces Third Quarter 2024 Financial Results NEWTOWN, Pa., Nov. 13, 2024 (GLOBE NEWSWIRE) -- NEWTOWN, Pa.  Forian Inc. (Nasdaq: FORA), a leading provider of data science driven information and analytics solutions to the life science, healthcare and financial services industries, today announced results for the quarter ended September 30, 2024. globenewswire.com - 3 days ago
VerticalScope Sets New Record for Monthly Active Users, Fueling Double-digit Revenue Growth and Strong Cash Flow in the Third Quarter of 2024 TORONTO--(BUSINESS WIRE)---- $FORA #VerticalScope--VerticalScope Holdings Inc. (“VerticalScope” or the “Company”) (TSX: FORA; OTCQX: VFORF), a technology company that has built and operates a cloud-based digital platform for online enthusiast communities, today announced financial results for the third quarter ended September 30, 2024 ("Q3" or "the quarter"). “Our team delivered another strong quarter in Q3 with momentum building in the business as we enter our strongest seasonal period to end the year,” said Rob Laidl. businesswire.com - 4 days ago
Forian Inc. to Participate in the 13th Annual ROTH MKM Technology Event NEWTOWN, Pa., Nov. 08, 2024 (GLOBE NEWSWIRE) -- Forian Inc. (Nasdaq: FORA) announces that Max Wygod, Chief Executive Officer and Executive Chairman, and Mike Vesey, Chief Financial Officer, will attend ROTH MKM's 13th annual Technology Event, which will be held on November 19th – 20th, 2024, at the Hard Rock Hotel in New York City. globenewswire.com - 1 week ago
Forian Inc. to Announce Third Quarter 2024 Results on November 13, 2024 NEWTOWN, Pa., Nov. 05, 2024 (GLOBE NEWSWIRE) -- Forian Inc. (Nasdaq: FORA), a provider of data science driven information and analytics solutions to the healthcare and life sciences industries, will announce its third quarter 2024 financial results on Wednesday, November 13, 2024, after the close of the market. The Company will host a conference call and webcast at 4:30 p.m. (ET) on November 13, 2024 to discuss the results. globenewswire.com - 1 week ago
Forian Acquires Kyber Data Science to Enhance Data Analytics Capabilities NEWTOWN, PA, Nov. 01, 2024 (GLOBE NEWSWIRE) -- Forian Inc. (Nasdaq: FORA), a provider of data science driven information and analytics solutions to the healthcare and life sciences industries, today announced it has acquired Kyber Data Science LLC (“Kyber”), a trusted provider of advanced healthcare data analytics and machine learning solutions to the financial services industry, from TD Cowen. This strategic acquisition strengthens Forian's position in the healthcare information marketplace through the addition of advanced analytics and software capabilities and expands the industries Forian serves to include financial services. globenewswire.com - 2 weeks ago
VerticalScope to Announce Third Quarter 2024 Results TORONTO--(BUSINESS WIRE)---- $FORA #earnings--VerticalScope Holdings Inc. ("VerticalScope" or the “Company”) (TSX: FORA; OTCQX: VFORF) announced today that the Company's third quarter 2024 financial results will be released after the market close on Tuesday, November 12, 2024. Management will host a conference call and webcast to discuss the Company's financial results at 8:00 a.m. ET on Wednesday, November 13, 2024. Live Call Registration and Webcast: https://events.q4inc.com/attendee/861368726 Joining Live by Te. businesswire.com - 1 month ago
VerticalScope Refinances Its Existing Senior Secured Credit Facility TORONTO--(BUSINESS WIRE)---- $FORA--VerticalScope Holdings Inc. (“VerticalScope” or the “Company”) (TSX: FORA; OTCQX: VFORF) announced today that it had entered into a second amended and restated credit agreement (such agreement, the “A&R Credit Agreement”), amending and restating the Company's existing credit agreement with Capital One (the “Existing Credit Agreement”). The A&R Credit Agreement was amended and restated to remove the single term loan tranche under the Existing Credit Agreement an. businesswire.com - 1 month ago
Forian Inc. (FORA) Q2 2024 Earnings Call Transcript Forian Inc. (NASDAQ:FORA ) Q2 2024 Earnings Conference Call August 14, 2024 4:30 PM ET Company Participants Max Wygod - Executive Chairman and CEO Michael Vesey - CFO Conference Call Participants Richard Baldry - ROTH Capital Partners Operator Greetings, and welcome to Forian's Second Quarter 2024 Financial Results Conference Call and Webcast. At this time, all participants are in listen-only mode. seekingalpha.com - 3 months ago
Forian Inc. (FORA) Reports Q2 Loss, Misses Revenue Estimates Forian Inc. (FORA) came out with a quarterly loss of $0.03 per share versus the Zacks Consensus Estimate of $0.03. This compares to loss of $0.03 per share a year ago. zacks.com - 3 months ago
Forian Inc. Announces Second Quarter 2024 Financial Results NEWTOWN, PA, Aug. 14, 2024 (GLOBE NEWSWIRE) -- Forian Inc. (Nasdaq: FORA), a provider of data science driven information and analytics solutions to the healthcare and life sciences industries, today announced results for the quarter ended June 30, 2024. globenewswire.com - 3 months ago
8. Profile Summary

Forian Inc. FORA

image
COUNTRY US
INDUSTRY Medical - Healthcare Information Services
MARKET CAP $ 62.2 M
Dividend Yield 0.00%
Description Forian Inc. provides software solutions, proprietary data driven insights, and predictive analytics to optimize the operational, clinical, and financial performance of its healthcare, cannabis, and government customers. It operates through three segments: Information & Software, Services, and Other. The company's products include BioTrack, a vertically integrated point of sale, manufacturing, delivery, and cultivator software solution for dispensaries, cultivators, manufacturers, and distributors; and Cannalytics, a Software as a Service based analytics solution that provides clients with a presentation of business performance. Its products also comprise BioTrack seed-to-sale compliance traceability platform, which is used to manage the tracking and tracing of various cannabis products from cultivation to sale; BioTrack State Traceability & Enforcement Monitoring System to ensure transparency and accountability throughout cannabis supply chain; and STEMS, a seed-to-sale tracking module, to provide cannabis program management solution to cannabis regulatory agencies. In addition, the company offers security monitoring and web marketing services. The company is headquartered in Newtown, Pennsylvania.
Contact 41 University Drive, Newtown, PA, 18940 https://forian.com
IPO Date March 3, 2021
Employees 36
Officers Mr. Max C. Wygod Co-Founder, Chief Executive Officer, President & Executive Chairman of the Board Mr. Jason Holden Vice President of Corporate Development Paul Reuscher Chief Commercial Officer Mr. Edward Francis Spaniel Jr. Executive Vice President, General Counsel & Secretary Mr. Adam H. Dublin Co-Founder, Chief Strategy Officer & Director